Orrick Advises Twist Bioscience on $70 Million IPO

October.31.2018

Orrick advised Twist Bioscience on its $70 million initial public offering of 5,000,000 shares of common stock. The offering priced at $14 per share and began trading on the Nasdaq Global Select Market on October 31, 2018 under the ticker symbol “TWST.” Founded in 2013, Twist manufactures synthetic genes and other DNA-based products. In addition to the offering, Twist has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the IPO price, less the underwriting discounts and commissions.

J.P. Morgan Securities LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. Allen & Company LLC and Robert W. Baird & Co. Incorporated acted as co-managers.

The Orrick team advising on the IPO was led by partners John Bautista, Pete Lamb and Christopher Austin and associates Vinella Sido, J.T. Ho and Hector Rodriguez, with additional assistance from partners Andrew Thorpe and Jason Flaherty, among others. Orrick has advised Twist since its inception.

Related Lawyers

John Bautista Partner, Technology Companies Group, Mergers & Acquisitions

San Francisco; Santa Monica; Silicon Valley

See my bio

D:+1 650 614 7652
E: [email protected]

Practice:

Technology & Innovation Sector
Technology Companies Group
Mergers & Acquisitions
Corporate Governance
Fintech
Blockchain and Virtual Currency

vCard

See full bio

John Bautista Partner

San Francisco; Santa Monica; Silicon Valley

John focuses his practice on advising emerging companies and investors, and represents both public and private high-tech and life sciences companies in many areas, including corporate and securities law, venture capital financings, mergers and acquisitions, public offerings, public company representation and technology licensing.

The Recorder named John the “2019 Innovator of the Year” for his work as the chief lawyer on the Long-Term Stock Exchange, a U.S. Securities and Exchange Commission-approved exchange designed to change the paradigm of traditional stock markets by rewarding entrepreneurs and investors committed to long-term business strategies. Financial Times recognized John as one of the Top 10 Most Innovative Individuals of the Year in 2017, calling him “one of the most influential lawyers in the technology ecosystem of Silicon Valley.” He is ranked Band 2 by Chambers USA California, for Venture Capital and Chambers USA Nationwide, ranked him Band 3 for Startups & Emerging Companies.

John is a Board member and co-founder of the Long-Term Stock Exchange, which is creating a new stock exchange for public companies supporting long-term investors, as well as an advisor and co-founder of Clerky.com, a company automating legal work for early-stage companies. He is also recognized for his work with Y Combinator companies.

Prior to joining Orrick, John was a founding attorney of Venture Law Group and served on the Executive Committee. John previously practiced at Wilson, Sonsini, Goodrich & Rosati. John also served as Mayor of the City of Cupertino, California and a council member from 1993-1997, where he helped build important public partnerships, including with Apple Computer, the Mid-Peninsula Open Space Preserve, and San Jose and California Water Companies.